Oppenheimer analyst Ken Wong initiates coverage on Squarespace (NYSE:SQSP) with a Perform rating.
Iovance Biotherapeutics Prices $211M Underwritten Offering of Common Stock to Support the Commercial Launch of AMTAGVI
Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) ("Iovance" or "Company"), a biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte